Since the above analysis implied that the PLEKHA4 expression was associated with immune response, tumor-related soluble factors, and ECM in LGG, it inferred that PLEKHA4 plays a vital role in the tumor-immune system interactions and TME formation in LGG patients. This evidence concerns the gene PLEKHA4 and neoplasm.